The 27th Congress of the European Hematology Association (EHA) 2022, held in Vienna, Austria, and virtually, from 9 - 12 June 2022, saw leading experts from around the world gather to discuss the most exciting updates in the field of hematology. Key updates on CAR-T therapy, transplant research, novel drugs, and more were showcased across the spectrum of hematological diseases, including CLL, AML, multiple myeloma, lymphomas, CML, ALL, sickle cell disease, thalassemia, and beyond.

View all videos

EHA 2022

09–12 June 2022 | Vienna Austria / Online

Retweet on Twitter VJHemOnc Retweeted

Ben Westphalen @BenWestphalen·

15 Jan 2022

What a pleasant surprise to see my @CccLmu @LMU_Muenchen colleague @KRejeski pop up on @VJHemOnc discussing the CAR-HEMATOTOX score developed by our departments @LMU_Immutherapy group led by @MSubklewe .

@OncoAlert 🚨 #hematology https://twitter.com/VJHemOnc/status/1482382472482639873

VJHemOnc@VJHemOnc

@VJHemOnc caught up w/ @KRejeski of @LMU_Muenchen on the use of the CAR-HEMATOTOX score to identify patients who are at risk of non-relapse mortality post #CART

Hear more on the team’s interesting findings: http://ow.ly/tCMO50HuuBz

#ASH21 @ASH_hematology #HemOnc #ImmunoOnc

Reply on Twitter 1482384248556380170 Retweet on Twitter 14823842485563801703 Like on Twitter 14823842485563801705 View Tweet 1482384248556380170

Retweet on Twitter VJHemOnc Retweeted

Raffaele Palmieri @RafPalmieri·

Thank you @VJHemOnc for the opportunity! https://www.vjhemonc.com/speaker/raffaele-palmieri/ https://twitter.com/vjhemonc/status/1640399029552005132

VJHemOnc@VJHemOnc

Last week, we had the pleasure of being in Munich at #ISAL2023, interviewing experts in AML and ALL, who shared some interesting insights & updates.

Check out our interviews here:

🎥: http://ow.ly/xjOL50MWU55

#AMLsm #ALLsm #LeuSM #ImmunoOnc #HemOnc #ISALXVIII

Reply on Twitter 1640449562031562763 Retweet on Twitter 16404495620315627631 Like on Twitter 16404495620315627635 View Tweet 1640449562031562763

VJHemOnc @VJHemOnc·

13h

Reply on Twitter 1640399029552005132 Retweet on Twitter 1640399029552005132 Like on Twitter 16403990295520051321 View Tweet 1640399029552005132

VJHemOnc @VJHemOnc·

19h

#ISAL2023 | @RaviMajetiMD of @Stanford shares some insights into how epigenetic analysis may be used to better understand the biology of relapse in patients with AML.

Watch here:

👉http://ow.ly/aqBN50Nr42B👈

#AMLsm #LeuSM #HemOnc

Reply on Twitter 1640308033665265664 Retweet on Twitter 1640308033665265664 Like on Twitter 16403080336652656641 View Tweet 1640308033665265664

VJHemOnc @VJHemOnc·

23h

#MyelomaAwarenessMonth is a great opportunity to discover the latest updates in myeloma.

For more, listen to our podcasts which cover a range of topics, including the role of MRD, immunotherapeutic approaches in myeloma, and more!

🎧: http://ow.ly/J5mT50N8kgr

#MMsm #HemOnc